摘要
目的 探讨钬激光前列腺剜除(HoLEP)术后暂时性尿失禁的相关危险因素,并建立术后尿失禁风险预测模型。方法 回顾分析2020年6月至2021年5月在本院接受HoLEP治疗的BPH患者的病历资料,所有的患者均进行了至少6个月的随访。采用多因素逐步回归法筛选术后暂时性尿失禁独立危险因素,并建立术后尿失禁临床预测模型。C指数与校准曲线分别用于评价模型的区分度与校准度。结果 共有140名符合条件的患者被纳入分析。多因素逐步回归分析显示:年龄≥70岁(OR=7.56,95%CI:2.21~31.61,P<0.01)、手术耗时≥100min(OR=12.70,95%CI:3.68~55.51,P<0.001)以及未使用膀胱颈保留技术(OR=44.79,95%CI:7.43~894,P<0.001)是Ho LEP术后暂时性尿失禁的独立危险因素。经内部验证,模型的C指数为0.92(95%CI:0.87~0.97),预测曲线紧贴理想曲线。结论 本研究建立的列线图模型对HoLEP术后暂时性尿失禁具有较高的预测价值,可用于识别高危患者并提供及时的干预,提高患者术后满意度。
Objective To identify a set of predictive factors to develop and validate risk prediction models for transient urinary incontinence following holmium laser enucleation of the prostate(HoLEP). Methods From June 2020 to May 2021, a retrospective review was performed on the medical records of BPH patients who underwent HoLEP at our institution. All the patients were followed up for at least six months. Multivariable step-wise regression analyses were used to screen for prognostic risk factors of urinary incontinence. The concordance index(C-index), calibration plots were employed to evaluate the accuracy and discriminatory ability of the model. Results A total of 140 patients were eligible and included in the analysis. Stepwise regression analysis indicated that age ≥ 70 years(OR=7.56,95%CI:2.21~31.61,P<0.01), operation time≥100 min(OR=12.70,95%CI:3.68~55.51,P<0.001) and the absence of bladder neck preserving technique(OR=44.79,95%CI:7.43-894,P<0.001) were significant predictors of UI. The C-index of the model was 0.92(95%CI:0.87~0.97) in the internal validation cohorts and calibration curves were close to 45° line. Conclusion The nomograms are of high efficacy in predicting transient urinary continence following HoLEP, which will be valuable in guiding postoper-ative interventions and increasing their satisfaction.
作者
郑嘉文
程红辉
邢诚诚
周丁亚
郑一春
HENG Jiawen;CHENG Honghui;XING Chengcheng(The Second Affiliated Hospital of Zhejiang University School of Medicine,Zhejiang 310009,China.)
出处
《浙江创伤外科》
2022年第4期618-622,共5页
Zhejiang Journal of Traumatic Surgery
基金
浙江省卫生健康委员会医药卫生科技项目(2020375998)。